Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| 1 |
Alibaba
BABA
|
+$138M |
| 2 |
AbbVie
ABBV
|
+$122M |
| 3 |
Zoom
ZM
|
+$109M |
| 4 |
Amazon
AMZN
|
+$105M |
| 5 |
Regeneron Pharmaceuticals
REGN
|
+$103M |
Top Sells
| 1 |
AGN
Allergan plc
AGN
|
+$226M |
| 2 |
RTN
Raytheon Company
RTN
|
+$145M |
| 3 |
Newmont
NEM
|
+$52.9M |
| 4 |
WBC
WABCO HOLDINGS INC.
WBC
|
+$51.2M |
| 5 |
Yum! Brands
YUM
|
+$34.4M |
Sector Composition
| 1 | Technology | 25.6% |
| 2 | Healthcare | 15.16% |
| 3 | Consumer Discretionary | 12.49% |
| 4 | Communication Services | 10.4% |
| 5 | Industrials | 8.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
EGRX
1976
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $1.24M | ﹤0.01% |
25,900
+4,700
| +22% | +$226K |
|
1977
Dave & Buster's
PLAY
$817M
| $1.24M | ﹤0.01% |
93,173
+33,400
| +56% | +$445K |
|
|
BMTC
1978
DELISTED
Bryn Mawr Bank Corp
BMTC
| $1.24M | ﹤0.01% |
44,900
+5,900
| +15% | +$163K |
|
1979
PC Connection
CNXN
$1.6B
| $1.24M | ﹤0.01% |
26,700
+3,700
| +16% | +$172K |
|
|
QUOT
1980
DELISTED
Quotient Technology Inc
QUOT
| $1.24M | ﹤0.01% |
168,800
+22,100
| +15% | +$162K |
|
|
ARR
1981
Armour Residential REIT
ARR
$1.72B
| $1.23M | ﹤0.01% |
26,282
+3,440
| +15% | +$162K |
|
|
ALX
1982
Alexander's
ALX
$1.25B
| $1.23M | ﹤0.01% |
5,100
+600
| +13% | +$145K |
|
1983
Ingles Markets
IMKTA
$1.32B
| $1.23M | ﹤0.01% |
28,500
+4,100
| +17% | +$177K |
|
|
CIO
1984
City Office REIT
CIO
$280M
| $1.23M | ﹤0.01% |
121,900
+16,100
| +15% | +$162K |
|
|
KRA
1985
DELISTED
Kraton Corporation
KRA
| $1.22M | ﹤0.01% |
70,800
+10,100
| +17% | +$174K |
|
1986
Corbus Pharmaceuticals
CRBP
$116M
| $1.22M | ﹤0.01% |
+4,853
| New | +$1.22M |
|
1987
AnaptysBio
ANAB
$655M
| $1.22M | ﹤0.01% |
54,600
+7,200
| +15% | +$161K |
|
1988
Center Bancorp
CNOB
$1.26B
| $1.22M | ﹤0.01% |
75,700
+9,900
| +15% | +$160K |
|
|
FSP
1989
Franklin Street Properties
FSP
$174M
| $1.22M | ﹤0.01% |
239,463
+31,500
| +15% | +$160K |
|
|
EBIX
1990
DELISTED
Ebix Inc
EBIX
| $1.22M | ﹤0.01% |
54,500
+7,200
| +15% | +$161K |
|
|
AVTA
1991
DELISTED
Avantax, Inc. Common Stock
AVTA
| $1.22M | ﹤0.01% |
106,600
+11,700
| +12% | +$134K |
|
1992
Evolent Health
EVH
$1.05B
| $1.22M | ﹤0.01% |
170,700
+24,200
| +17% | +$172K |
|
|
PRVB
1993
DELISTED
Provention Bio, Inc. Common Stock
PRVB
| $1.22M | ﹤0.01% |
+86,100
| New | +$1.22M |
|
|
CKH
1994
DELISTED
Seacor Holdings Inc.
CKH
| $1.21M | ﹤0.01% |
42,800
+5,600
| +15% | +$159K |
|
|
ODT
1995
DELISTED
Odonate Therapeutics, Inc. Common Stock
ODT
| $1.21M | ﹤0.01% |
28,600
+900
| +3% | +$38.1K |
|
1996
Ecovyst
ECVT
$1.06B
| $1.21M | ﹤0.01% |
91,400
+12,000
| +15% | +$159K |
|
|
SWTX
1997
DELISTED
SpringWorks Therapeutics
SWTX
| $1.21M | ﹤0.01% |
+28,800
| New | +$1.21M |
|
1998
Anika Therapeutics
ANIK
$125M
| $1.2M | ﹤0.01% |
31,900
+4,200
| +15% | +$159K |
|
1999
Rhythm Pharmaceuticals
RYTM
$6.39B
| $1.2M | ﹤0.01% |
54,000
-5,600
| -9% | -$125K |
|
2000
Quanterix
QTRX
$224M
| $1.2M | ﹤0.01% |
43,800
+16,600
| +61% | +$455K |
|